Cho BC - Search Results

1

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer.

Sohn JH, Choi HJ, Chang J, Kim SK, Lee CG, Chung KY, Kim DJ, Cho BC, Shin SJ, Moon YW, Kim JH. Sohn JH, et al. Among authors: cho bc. Lung Cancer. 2006 Dec;54(3):365-70. doi: 10.1016/j.lungcan.2006.08.014. Epub 2006 Sep 29. Lung Cancer. 2006. PMID: 17011068 Clinical Trial.

2

Congenital absence of inferior vena cava as a rare cause of pulmonary thromboembolism.

Cho BC, Choi HJ, Kang SM, Chang J, Lee SM, Yang DG, Hong YK, Lee DH, Lee YW, Kim SK. Cho BC, et al. Yonsei Med J. 2004 Oct 31;45(5):947-51. doi: 10.3349/ymj.2004.45.5.947. Yonsei Med J. 2004. PMID: 15515211 Free article.

3

A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.

Cho BC, Kim EH, Choi HJ, Kim JH, Roh JK, Chung HC, Ahn JB, Lee JD, Lee JT, Yoo NC, Sohn JH. Cho BC, et al. Yonsei Med J. 2005 Dec 31;46(6):799-805. doi: 10.3349/ymj.2005.46.6.799. Yonsei Med J. 2005. PMID: 16385656 Free PMC article.

4

Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.

Cho BC, Kim JH, Kim CB, Sohn JH, Choi HJ, Lee YC, Ahn JB. Cho BC, et al. Oncol Rep. 2006 Mar;15(3):621-7. Oncol Rep. 2006. PMID: 16465422 Clinical Trial.

5

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO. Lee YS, et al. Among authors: cho s, cho bc. Clin Cancer Res. 2006 Oct 1;12(19):5859-68. doi: 10.1158/1078-0432.CCR-06-0935. Clin Cancer Res. 2006. PMID: 17020994 Free article.

6

Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.

Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC. Cho BC, et al. J Surg Oncol. 2007 May 1;95(6):461-8. doi: 10.1002/jso.20731. J Surg Oncol. 2007. PMID: 17192913

7

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer.

Shin SJ, Ahn JB, Choi HJ, Cho BC, Jeung HC, Rha SY, Chung HC, Roh JK. Shin SJ, et al. Among authors: cho bc. Cancer Chemother Pharmacol. 2008 Jan;61(1):75-81. doi: 10.1007/s00280-007-0447-2. Epub 2007 Mar 21. Cancer Chemother Pharmacol. 2008. PMID: 17375304 Clinical Trial.

8

Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.

Shin SJ, Jeung HC, Ahn JB, Choi HJ, Cho BC, Rha SY, Yoo NC, Roh JK, Chung HC. Shin SJ, et al. Among authors: cho bc. Cancer Chemother Pharmacol. 2008 Jan;61(1):157-65. doi: 10.1007/s00280-007-0470-3. Epub 2007 Apr 11. Cancer Chemother Pharmacol. 2008. PMID: 17426971 Clinical Trial.

9

Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy.

Shin SJ, Lee HW, Kim SH, Ahn JB, Choi HJ, Cho BC, Jeung HC, Rha SY, Chung HC, Pyo JY, Roh JK. Shin SJ, et al. Among authors: cho bc. Acta Oncol. 2007;46(4):547-9. doi: 10.1080/02841860601009463. Acta Oncol. 2007. PMID: 17497323 No abstract available.

10

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.

Choi HJ, Cho BC, Shin SJ, Cheon SH, Jung JY, Chang J, Kim SK, Sohn JH, Kim JH. Choi HJ, et al. Among authors: cho bc. Cancer Chemother Pharmacol. 2008 Feb;61(2):309-13. doi: 10.1007/s00280-007-0505-9. Epub 2007 Jun 19. Cancer Chemother Pharmacol. 2008. PMID: 17576560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters